Digital health companies need to show economic evidence for their solutions, but building that evidence can be very difficult, especially for small companies that are new in the market. Real-world data (RWD) offers an opportunity to help build the evidence needed. Join this masterclass led by Imperial College Health Partners, where we will focus on the potential use of RWD to build economic evidence for digital health market access. Amanda Lucas (Director of Information) and Reuben Lewis (Associate Director for Analytics and Data Partnerships) will walk us through:
The value proposition of RWD. What are the benefits and challenges of using RWD to build evidence? Is it more or less valuable than clinical trials?
Sharing success with commercial and system partnerships. How can we create more collective impact by working collaboratively, rather than competitively?
Creating acceptable data access. What governance structures, PPIE processes and agreements need to be in place to ensure the use of real-world evidence is not publicly disputed?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.